Ian T. Clark resigns from Corvus board effective July 22, 2026TradingView·Jul 22 at 03:03 PMCRVS+1.61%
The Economy's Long Tail: What 10 Outliers Tell Us About the 2026 Market RealityGlobal Report·Jul 21 at 04:13 AMTOYO-1.24%ABCL+1.60%
10 Health Care Stocks With Whale Alerts In Today’s Sessionbenzinga_article·Jul 1 at 12:35 PMCRSP+2.21%PURR+2.42%
Top Corvus Pharmaceuticals Insider Makes Bold New Bet on the Company’s FutureTip Ranks·Jun 15 at 09:14 PMCRVS+1.61%
Mizuho Securities Sticks to Their Buy Rating for Corvus Pharmaceuticals (CRVS)Tip Ranks·Jun 12 at 09:25 AMCRVS+1.61%
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference | CRVS Stock NewsStockTitan·May 20 at 07:01 AMCRVS+1.61%XBI+1.59%
Corvus Pharmaceuticals (CRVS) Gets a Buy from OppenheimerTip Ranks·May 15 at 07:02 AMCRVS+1.61%FBT+1.34%
Corvus Pharmaceuticals presents Phase 1 soquelitinib data showing durable remissions, favorable safetyTradingView·May 14 at 06:03 AMCRVS+1.61%XBI+1.59%